| Structure | Chemical Name | CAS | MF |
|
Stannane, 1,1'-(1,10-decanediyldi-5,2-thiophenediyl)bis[1,1,1-trimethyl-
|
1884354-25-9
|
C24H42S2Sn2
|
|
Sofosbuvir Impurity 7
|
1884385-12-9
|
C20H19FO6
|
|
(2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)thiazol-5-yl)boronic acid pinacol ester
|
1884388-16-2
|
C19H31BN2O4S
|
|
Terlipressin Diacetate Salt
|
1884420-36-3
|
C54H78N16O17S2
|
|
2,7-Bis(4-bromophenyl)-9-hexyl-9H-carbazole
|
1884420-79-4
|
C30H27Br2N
|
|
(2R,3R)-2-benzyl-3-(tert-butyl)-4-(2,6-dimethoxyphenyl)-2,3-dihydrobenzo[d][1,3]oxaphosphole
|
1884457-36-6
|
C26H29O3P
|
|
(R)-1-(3-(tert-butyl)-2,3-dihydrobenzo[d][1,3]oxaphosphol-4-yl)-2,5-diphenyl-1H-pyrrole
|
1884457-40-2
|
C27H26NOP
|
|
3-(bromodifluoromethyl)-5-methyl-1H-pyrazole
|
1884457-49-1
|
C5H5BrF2N2
|
|
Ensifentrine
|
1884461-72-6
|
C26H31N5O4
|
|
2-Benzyloxy-4-cyanophenylboronic acid
|
1884477-63-7
|
C14H12BNO3
|
|
4-(6-Methyl-4,8-dioxo-1,3,6,2-dioxazaborocan-2-yl)benzonitrile
|
1884492-36-7
|
C12H11BN2O4
|
|
methyl 3-hydroxyazetidine-3-carboxylate hydrochloride
|
1884493-19-9
|
C5H10ClNO3
|
|
1-benzyl 3-methyl 3-hydroxyazetidine-1,3-dicarboxylate
|
1884493-20-2
|
C13H15NO5
|
|
ibact
|
1884575-91-0
|
C33H50Cl2N10O2
|
|
n-1
|
1884576-18-4
|
C30H39N6O8P
|
|
Boc-Val-Ala-PAB
|
1884577-99-4
|
C20H31N3O5
|
|
Boc-Val-Ala-PAB-PNP
|
1884578-00-0
|
C27H34N4O9
|
|
Alloc-Val-Ala-PAB-PNP
|
1884578-27-1
|
C26H30N4O9
|
|
(2S,3S)-4-(anthracen-9-yl)-3-(tert-butyl)-2-methyl-2,3-dihydrobenzo[d][1,3]oxaphosphole
|
1884594-02-8
|
C26H25OP
|
|
(2S,3S)-4-(anthracen-9-yl)-3-(tert-butyl)-2-ethyl-2,3-dihydrobenzo[d][1,3]oxaphosphole
|
1884594-03-9
|
C27H27OP
|
|
2-Chloro-4-(naphthalen-1-yl)-6-phenyl-pyrimidine
|
1884599-54-5
|
C20H13ClN2
|
|
methyl 2,5-di(thiophen-2-yl)benzoate
|
1884635-19-1
|
C16H12O2S2
|
|
4-Cyano-N-(1,2-dihydro-1,3-dimethyl-2-oxo-6-quinolinyl)benzenesulfonamide
|
1884640-99-6
|
C18H15N3O3S
|
|
(R)-2-amino-4-(2-((4-(2-((2-hydroxy-2-phenylethyl)amino)ethyl) phenyl)amino)-2-oxoethyl)thiazole 3-oxide
|
1884646-38-1
|
C21H24N4O3S
|
|
(2R,2'R,3R,3'R)-4,4'-di(ant
hracen-9-yl)-3,3'-di-tert-bu
tyl-2,2',3,3'-tetrahydro-2,2'
-bibenzo[d][1,3]oxaphosp
hole
|
1884680-45-8
|
C50H44O2P2
|
|
(2R,2'R,3R,3'R)-3,3'-di-tert-butyl-4,4'-bis(2,6-dimethoxyphenyl)-2,2',3,3'-tetrahydro-2,2'-bibenzo[d][1,3]oxaphosphole
|
1884680-48-1
|
C38H44O6P2
|
|
IDT-C6benzene-Dialdehyde
|
1884694-93-2
|
C66H74O2S2
|
|
Cyclopropanecarboxamide, N-(3R)-3-pyrrolidinyl-, hydrochloride
|
1884705-03-6
|
C8H15ClN2O
|
|
Cbz-B3A
|
1884710-81-9
|
C35H58N6O9
|
|
cpi-637
|
1884712-47-3
|
C22H22N6O
|
|
(R)-6-Bromo-4-methyl-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one
|
1884712-55-3
|
C10H11BrN2O
|
|
4-(but-3-yn-1-yl)piperidine hydrochloride
|
1885090-83-4
|
C9H16ClN
|
|
Vonoprazan Fumarate impurity
|
1885094-62-1
|
C18H18FN3O2S
|
|
Benzoic acid, 4,4',4'',4'''-(2,5,8,11-perylenetetrayl)tetrakis-
|
1885094-82-5
|
C48H28O8
|
|
4-Chloro-5-fluoro-2-methylphenylboronic acid pinacol ester
|
1885096-92-3
|
C13H17BClFO2
|
|
2-Bromo-4-methoxy-5-nitro-benzoic acid methyl ester
|
1885103-93-4
|
C9H8BrNO5
|
|
Obeticholic Impurity 12
|
1885104-64-2
|
C26H42O4
|
|
ELA-14 negative control
|
1885873-44-8
|
C72H112N22O17S2
|
|
4,4',4'',4'''-((1,4,8,11-tetraazacyclotetradecane-1,4,8,11-tetrayl)tetrakis(methylene))tetrabenzoic acid
|
1886010-85-0
|
C42H48N4O8
|
|
5,10,15,20-Tetrakis(4-hydroxyphenyl)porphyrin
|
1886081-85-1
|
C48H30N20
|
|
Brexpiprazole Impurity 7
|
1886188-97-1
|
C13H15NO3
|
|
rel-tert-butyl (3R,4R)-3-amino-4-(hydroxymethyl)pyrrolidine-1-carboxylate
|
1886799-52-5
|
C10H20N2O3
|
|
FeBuxostat Impurity 26
|
1886961-39-2
|
C14H12N2O3S
|
|
3-Isopropylbicyclo[1.1.1]pentan-1-amine hydrochloride
|
1886967-00-5
|
C8H16ClN
|
|
N-methylbicyclo[1.1.1]pentan-1-amine hydrochloride
|
1886967-09-4
|
C6H12ClN
|
|
3-methanesulfonylbicyclo[1.1.1]pentan-1-amine
|
1886967-22-1
|
C6H11NO2S
|
|
3-chlorobicyclo[1.1.1]pentan-1-amine hydrochloride
|
1886967-25-4
|
C5H9Cl2N
|
|
3-(difluoromethyl)bicyclo[1.1.1]pentan-1-amine
|
1886967-47-0
|
C6H9F2N
|
|
tert-butyl (3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl)carbamate
|
1886967-53-8
|
C11H16F3NO2
|
|
3-tert-butylbicyclo[1.1.1]pentan-1-amine
|
1886967-57-2
|
C9H18ClN
|
|
2-[3-(trifluoromethyl)bicyclo[1.1.1]pentan-1-yl]acetic acid
|
1886967-65-2
|
C8H9F3O2
|
|
3-methanesulfonylbicyclo[1.1.1]pentane-1-carboxylic acid
|
1886967-73-2
|
C7H10O4S
|
|
3-(1,1-difluoroethyl)bicyclo[1.1.1]pentane-1-carboxylic acid
|
1886967-78-7
|
C8H10F2O2
|
|
ELA-14 (human)
|
1886973-05-2
|
C75H119N25O17S2
|
|
4'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-carboxylic acid
|
1886974-43-1
|
C14H10N4O2
|
|
2-(4-(difluoromethyl)phenyl)-2,2-difluoroethanol
|
1886990-13-1
|
C9H8F4O
|
|
ethyl 3-amino-1H-pyrazole-5-carboxylate
|
1886994-04-2
|
C6H9N3O2
|
|
Ethyl 3-bromo-1H-pyrazole-5-carboxylate
|
1886994-07-5
|
C6H7BrN2O2
|
|
Methanesulfonic acid, 1,1,1-trifluoro-, 6-[(1-methylethyl)thio]-1,3-dioxo-1H-benz[de]isoquinolin-2(3H)-yl ester
|
1887001-94-6
|
C16H12F3NO5S2
|
|
(S)-3-(1-aminoethyl)-6-chloroquinolin-2(1H)-one
|
1887009-48-4
|
C11H12Cl2N2O
|
|
Olutasidenib
|
1887014-12-1
|
C18H15ClN4O2
|
|
5-[[(1R)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxo-pyridine-2-carbonitrile
|
1887014-14-3
|
C18H15ClN4O2
|
|
2-Pyridinecarbonitrile, 5-fluoro-1,6-dihydro-1-methyl-6-oxo-
|
1887015-55-5
|
C7H5FN2O
|
|
(S)-(2,2-difluorocyclopropyl)methanol
|
1887036-19-2
|
C4H6F2O
|
|
4-Nitrophenyl 2-(pyridin-2-yldisulfanyl)propyl carbonate
|
1887040-81-4
|
C15H14N2O5S2
|
|
β-D-Glucopyranoside, 2-[[[[(1S)-1-hydroxy-6-oxo-2-cyclohexen-1-yl]carbonyl]oxy]methyl]phenyl
|
1887055-63-1
|
C20H24O10
|
|
AOEGVETYSHPGBP-XYIDDFOTSA-N
|
1887057-05-7
|
C41H55NO14
|
|
tert-butyl (1-(6-chloropyridin-3-yl)cyclobutyl)carbamate
|
1887059-70-2
|
C14H19ClN2O2
|
|
4'-(4-carboxyphenyl)-[2,2':6',2''-terpyridine]-5,5''-dicarboxylic acid
|
1887067-79-9
|
C24H15N3O6
|
|
8H-[1,4]Diazepino[5',6':4,5]thieno[3,2-f]quinolin-8-one, 3-[[2-chloro-5-(ethoxymethyl)-4-pyrimidinyl]oxy]-9,10,11,12-tetrahydro-10-methyl-, (10R)-
|
1887069-10-4
|
C22 H20 Cl N5 O3 S
|
|
Iridium(1+), bis[3,5-difluoro-2-(2-pyridinyl-κN)phenyl-κC](4,4'-dimethoxy-2,2'-bipyridine-κN1,κN1')-, (OC-6-33)-, hexafluorophosphate(1-) (1:1)
|
1887093-05-1
|
C34H24F10IrN4O2P
|
|
Diethyl 4-vinylpyridine-2,6-dicarboxylate
|
1887093-15-3
|
C13H15NO4
|
|
Carbamic acid, N-[4-[4-amino-3-(2-amino-5-benzoxazolyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]butyl]-, 1,1-dimethylethyl ester
|
1887095-80-8
|
C21H26N8O3
|
|
RapaLink-1
|
1887095-82-0
|
C91H138N12O24
|
|
Phenol, 3-fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-
|
1887126-77-3
|
C12H16BFO3
|
|
4,7-bis(5-bromothiophen-2-yl)-5,6-difluoro-2-(2-hexyldecyl)-2H-benzo[d][1,2,3]triazole
|
1887135-96-7
|
C30H37Br2F2N3S2
|
|
IN1705, (4,8-Bis(5-(dodecylthio)thiophen-2-yl)benzo[1,2-b:4,5-b']dithiophene-2,6-diyl)bis(trimethylstannane)
|
1887135-97-8
|
C48H74S6Sn2
|
|
J61
|
1887136-00-6
|
C78H111Br2F2N3S8Sn2
|
|
J52
|
1887136-01-7
|
(C64H77F2N3S6)n
|
|
PBDT-S-BTZ
|
1887136-02-8
|
|
|
RORγt Inverse agonist 6
|
1887161-80-9
|
C28H29ClN6O5
|
|
tert-butyl endo-3-amino-9-azabicyclo[3.3.1]nonane-9-carboxylate
|
1887167-87-4
|
C13H24N2O2
|
|
(R)-1,5-Dimethylpiperazin-2-one hydrochloride
|
1887197-41-2
|
C6H13ClN2O
|
|
N'-((2S,3S)-2-(Benzyloxy)pentan-3-yl)formohydrazide oxalate
|
1887197-42-3
|
C15H22N2O6
|
|
(S)-1,5-Dimethylpiperazin-2-one hydrochloride
|
1887197-43-4
|
C6H13ClN2O
|
|
(5-((tert-Butoxycarbonyl)amino)-2-methylpyridin-3-yl)boronic acid pinacol ester
|
1887223-13-3
|
C17H27BN2O4
|
|
tert-butyl 5-bromo-2-oxospiro[indoline-3,3-pyrrolidine]-1-carboxylate(WX106482)
|
1887237-17-3
|
C16H19BrN2O3
|
|
3-Pyridinecarbonitrile, 6-chloro-2-iodo-
|
1887237-28-6
|
C6H2ClIN2
|
|
6-Quinolinecarboxamide, 1-acetyl-4-[(5-chloro-2-pyrimidinyl)amino]-1,2,3,4-tetrahydro-2-methyl-, (2S,4R)-
|
1887237-54-8
|
C17H18ClN5O2
|
|
2,6-Dichloro-4-(trifluoromethyl)phenylboronic acid
|
1887240-36-9
|
C7H4BCl2F3O2
|
|
2,3,6-Tri-O-benzyl-1-O-(thexyldimethylsilyl)-β-D-galactopyranose
|
1887760-18-0
|
C35H48O6Si
|
|
Ethyl 2-[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy]propanoate
|
1887769-37-0
|
C17H25BO5
|
|
5-Bromo-2-iodo-1-methoxy-3-methyl-benzene
|
1887769-55-2
|
C8H8BrIO
|
|
X60
|
1887794-22-0
|
C81H68N4O9
|
|
ethyl 1-(2-methyl-4-(3-methyl-1H-pyrazol-1-yl)benzoyl)-5-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepine-4-carboxylate
|
1888294-91-4
|
C25H25N3O4
|
|
ERK5-IN-2
|
1888305-96-1
|
C17H11BrFN3O2
|
|
Infrared absorber 792
|
1888324-74-0
|
C49H56BF4N3
|
|
EPZ 025654
|
1888328-89-9
|
C29H33ClN8O3
|
|
1,2,4-Oxadiazol-5(4H)-one, 4-(3-bromo-4- fluorophenyl)-3-[4-[[2-(methylthio)ethyl]amino]- 1,2,5-oxadiazol-3-yl]-
|
1888341-29-4
|
C13H11BrFN5O3S
|
|
IDO-IN-9
|
1888378-12-8
|
C13H13BrFN7O3S
|